Summary
Gilbert’s syndrome is an inherited disorder which is characterised by unconjugated hyper-bilirubinaemia. In patients with Gilbert’s syndrome, both bilirubin clearance and in vitro hepatic microsomal uridine diphosphoglucuronyl transferase (UDPGT) activity are reduced. In addition, there is evidence suggesting impaired hepatic uptake of bilirubin in Gilbert’s syndrome.
Glucuronidation of a number of substrates appears to be impaired in Gilbert’s syndrome, but the significance of the reported changes in oxidation and acetylation are less clear.
Similar content being viewed by others
References
Adlercreutz, H. and Tikkanen, M.J.: Defects in hepatic uptake and transport and biliary excretion of estrogens. Medecine et Chirurgie Digestives 2: 59–65 (1973).
Auclair, C.; Hakim, J.; Boivin, P.; Troube, H. and Boucherot, J.: Bilirubin and paranitrophenol glucuronyl transferase activities of the liver in patients with Gilbert’s syndrome. Enzyme 21: 97–107 (1976).
Bailey, A.; Robinson, D. and Dawson, A.M.: Does Gilbert’s disease exist?. Lancet 1: 931–933 (1977).
Barrett, P.V.D.: Effects of caloric and non-caloric materials in fasting hyperbilirubinaemia. Gastroenterology 68: 361–369 (1975).
Beck, K. and Kiani, B.: Zur frage der glucuronbildung bei der funktionellen hyperbilirubinamie unter berucksichtigung der renalen glucuronid-clearance. Klinische Wochenschrift 38: 428–433 (1960).
Berk, P.D.; Blaschke, T.F.; Scharschmidt, B.F.; Waggoner, J.G. and Berlin, N.I.: A new approach to quantitation of the various sources of bilirubin in man. Journal of Laboratory and Clinical Medicine 87: 767–780 (1976).
Berk, P.D.; Blaschke, T.F. and Waggoner, J.G.: Defective bromsulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert’s Syndrome). Gastroenterology 63: 472–481 (1972).
Berk, P.D.; Bloomer, J.R.; Howe, R.B. and Berlin, N.I.: Constitutional hepatic dysfunction (Gilbert’s syndrome). American Journal of Medicine 49: 296–305 (1970).
Berk, P.D.; Howe, R.B.; Bloomer, J.R. and Berlin, N.I.: Studies of Bilirubin kinetics in normal adults. Journal of Clinical Investigation 48: 2176–2190 (1969).
Berk, P.D.; Wolkoff, A.W. and Berlin, N.I.: Inborn errors of bilirubin metabolism. Medical Clinics of North America 59: 803–816 (1975).
Billing, B.H.; Williams, R. and Richards, T.G.: Defects in hepatic transport of bilirubin in congenital hyperbilirubinaemia: an analysis of plasma bilirubin disappearance curves. Clinical Science 27: 245–257 (1964).
Black, M. and Billing, B.H.: Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert’s syndrome. New England Journal of Medicine 280: 1266–1271 (1969).
Black, M.; Fevery, J.; Parker, D.; Jacobson, J.; Billing, B.H. and Carson, E.R.: Effect of phenobarbitone on plasma 14C-bilirubin clearance in patients with unconjugated hyperbilirubinaemia. Clinical Science and Molecular Medicine 46: 1–17 (1974).
Black, M. and Sherlock, S.: Treatment of Gilbert’s syndrome with phenobarbitone. Lancet 1: 1359–1362 (1970).
Blanckaert, N.; Gollan, J.L. and Schmid, R.: Is bilirubin glucuronide found in vivo by transglucuronidation of bilirubin monoglucuronide. Gastroenterology 74: 1166 (1978).
Blaschke, T.F.; Berk, P.D.; Rodkey, F.L.; Scharschmidt, B.F.; Collison, H.A. and Waggoner, J.G.: Drugs and the liver 1. Effects of glutethimide and phenobarbital in hepatic bilirubin clearance, plasma bilirubin turnover and carbon monoxide production in man. Biochemical Pharmacology 23: 2795–2806 (1974).
Carulli, N.; Ponz de Leon, M.; Mauro, E.; Manenti, F. and Ferrari, A.: Alteration of drug metabolism in Gilbert’s syndrome. Gut 17: 581–587 (1976).
Davidson, A.R.; Rojas-Bueno, A.; Thompson, R.P.H. and Williams, R.: Reduced calorie intake and nicotinic acid provocation tests in the diagnosis of Gilbert’s syndrome. British Medical Journal 2: 480 (1975).
Davis, D.R. and Yearly, R.A.: Bilirubin binding to hepatic Y and Z protein (Ligandin): Tissue bilirubin concentrations in phenobarbital treated Gunn rats. Proceedings of the Society for Experimental Biology and Medicine 148: 9–13 (1975).
Dawson, J.; Carr-Locke, D.L.; Talbot, I.C. and Rosenthal, F.D.: Hepatic ultrastructure in Gilbert’s syndrome: evidence for two populations. Gut 19: A995 (1978).
Douglas, A.P.; Savage, R.L. and Rawlins, M.D.: Paracetamol (Acetaminophen) kinetics in patients with Gilbert’s syndrome. European Journal of Clinical Pharmacology 13: 209–212 (1978).
Egger, G.; Kurz, K.; Bachofen, H. and Preisig, R.: Simple method to estimate hepatic bilirubin clearance: its application in the differential diagnosis of Gilbert’s disease. Digestion 10: 225 (1974).
Evans, D.A.P.: An improved and simplified method of detecting the acetylator phenotype. Journal of Medical Genetics 6: 405–407 (1969).
Felsher, B.F.: Effect of changes in dietary components on the serum bilirubin in Gilbert’s syndrome. American Journal of Clinical Nutrition 29: 705–709 (1976).
Felsher, B.F.; Craig, J.R. and Carpio, N.: Hepatic bilirubin glucuronidation in Gilbert’s syndrome. Journal of Laboratory and Clinical Medicine 81: 829–837 (1973).
Felsher, B.F.; Rickard, D. and Redeker, A.G.: The reciprocal relation between caloric intake and the degree of hyperbilirubinaemia in Gilbert’s syndrome. The New England Journal of Medicine 283: 170–172 (1970).
Fevery, J.; Blanckaert, N.; Heirwegh, K.P.M.; Preaux, A. and Berthelot, P.: Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert’s syndrome and Crigler-Najjar Disease. Journal of Clinical Investigation 60: 970–979 (1977).
Foulk, W.T.; Butt, H.R.; Owen, C.A.; Whitcomb, F.F. and Mason, H.L.: Constitutional hepatic dysfunction (Gilbert’s disease): its natural history and related syndromes. Medicine (Baltimore) 38: 25–46 (1959).
Frezza, M. and Tiribelli, C.: The involvement of cytoplasmic BSP binding proteins in Gilbert’s syndrome. Digestion 10: 314–315 (1974).
Fromke, V.L. and Miller, D.: Constitutional hepatic dysfunction (Gilbert’s disease); a review with special reference to a characteristic increase and prolongation of the hyperbilirubinaemic response to nicotinic acid. Medicine (Baltimore) 51: 451–464 (1972).
Gilbert, A. and Lereboullet, P.: La Cholemie simple familiale. Semaine Medicale 21: 241 (1901).
Gollan, J.L.; Bateman, C. and Billing, B.H.: Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert’s syndrome. Gut 17: 335–340 (1976).
Goresky, C.A.; Gordon, E.R.; Shaffer, E.A.; Pare, P.; Carassavas, D. and Aronoff, A.: Definition of a conjugation dysfunction in Gilbert’s syndrome: studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clinical Science and Molecular Medicine 55: 63–71 (1978).
Jacobsen, J.: Binding of bilirubin to human serum albumin —determination of the dissociation constants. Febs Letters 5: 112–114 (1969).
Jansen, P.L.M.; Chowdhury, J.R.; Fischberg, E.B. and Arias, I.M.: Enzymatic conversion of bilirubin monoglucuronide to diglucuronide by rat liver plasma membranes. Journal of Biological Chemistry 252: 2710–2716 (1977).
Levi, A.J.; Gatmaitan, Z. and Arias, I.M.: Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. Journal of Clinical Investigation 48: 2156–2167 (1969).
Martin, J.F.; Vierling, J.M.; Wolkoff, A.W.; Scharschmidt, B.F.; Vergalla, J.; Waggoner, J.G. and Berk, P.D.: Abnormal hepatic transport of indocyanine green in Gilbert’s syndrome. Gastroenterology 70: 385–391 (1976).
McGee, J.O’D.; Allan, J.G.; Russell, R.I. and Patrick, R.S.: Liver ultrastructure in Gilbert’s syndrome. Gut 16: 220–224 (1975).
Metge, W.R.; Owen, C.A.; Foulk, W.T. and Hoffman, H.N.: Bilirubin glucuronyl transferase activity in liver disease. Journal of Laboratory and Clinical Medicine 64: 89–98 (1964).
Okolicsanyi, L.; Ghidini, O.; Orlando, R.; Cortelazzo, S.; Benedetti, G.; Naccarato, R. and Manitto, P.: An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert’s syndrome. Clinical Science and Molecular Medicine 54: 539–547 (1978).
Owens, D. and Evans, J.: Population studies on Gilbert’s syndrome. Journal of Medical Genetics 12: 152–156 (1975).
Owens, D. and Sherlock, S.: Diagnosis of Gilbert’s syndrome: role of reduced caloric intake test. British Medical Journal 3: 559–563 (1973).
Penner, E.; Mayr, W.R.; Djawan, S.; Seyfried, H. and Pacher, M.: Untersuchungen zur genetik des Gilbert-syndroms. Schweizerische Medizinische Wochenschrift 106: 860–862 (1976).
Platzer, R.; Kupfer, A.; Bircher, J. and Preisig, R.: Polymorphic acetylation and aminopyrine demethylation in Gilbert’s syndrome. European Journal of Clinical Investigation 8: 219–223 (1978).
Powell, L.W.; Billing, B.H. and Williams, H.S.: An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert’s syndrome) by the use of radioactive diisopropylfluorophospate and chromium. Australasian Annals of Medicine 16: 221–225 (1967a).
Powell, L.W.; Hemingway, E.; Billing, B.H. and Sherlock, S.: Idiopathic unconjugated hyperbilirubinaemia (Gilbert’s syndrome) — a study of 42 families. New England Journal of Medicine 277: 1108–1112 (1967b).
Raymond, G.D. and Galambos, J.T.: Hepatic storage and excretion of bilirubin in man. American Journal of Gastroenterology 55: 135–144 (1971).
Sherlock, S.: Gilbert’s syndrome; in Diseases of the Liver and Biliary System, 5th ed, p. 249 (Blackwell Scientific Publications, Oxford 1975).
Wolkoff, A.W.; Ketley, J.N.; Waggoner, J.G.; Berk, P.D. and Jakoby, W.B.: Hepatic accumulation and intracellular binding of conjugated bilirubin. Journal of Clinical Investigation 61: 142–149 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Macklon, A.F., Savage, R.L. & Rawlins, M.D. Gilbert’s Syndrome and Drug Metabolism. Clin Pharmacokinet 4, 223–232 (1979). https://doi.org/10.2165/00003088-197904030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197904030-00004